Morbidity and Sjögren's syndrome. New approaches in the treatment of chronic tonsillitis and acute tonsillopharyngitis
Modern epidemiological data indicate that the etiology and pathogenesis of diseases of the throat and ear remain not fully understood [1]. As is known, the most common manifestations of pathology of the ENT organs are chronic tonsillitis (CT) and acute tonsillopharyngitis (ATP), which belong to a nosoform that has a viral etiology, as well as a bacterial etiology. A pathogenetically important point for each pathology is the presence of specific changes in the immune system of patients. Currently, the diagnosis of the underlying disease is based on a clinical analysis of symptoms and diagnosis of diseases associated with the patient having a chronic and acute infection of the oral cavity, or the detection of infectious lesions of the ENT organs. This confirms damage to the gastrointestinal tract, endocrine system, respiratory system and decreased immunity. In recent years, there has been an increase in the incidence of any inflammatory processes associated with the emergence of acute respiratory infections throughout the world. This problem is one of the many social threats to public health, important both from the point of view of economic losses from temporary disability and the danger of the spread of concomitant infections. Sjögren's syndrome (SS) is a complex immune-dependent multisystem